Australian Institute of Health and Welfare. Cancer data in Australia. Canberra: AIHW; 2021.
Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet. 2013;381(9868):752–62. https://doi.org/10.1016/s0140-6736(12)62167-9
Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I, et al. A global clinical measure of fitness and frailty in elderly people. Cmaj. 2005;173(5):489–95. https://doi.org/10.1503/cmaj.050051
Article PubMed PubMed Central Google Scholar
Burn R, Hubbard RE, Scrase RJ, Abey-Nesbit RK, Peel NM, Schluter PJ, et al. A frailty index derived from a standardized comprehensive geriatric assessment predicts mortality and aged residential care admission. BMC Geriatr. 2018;18(1):319. https://doi.org/10.1186/s12877-018-1016-8
Article PubMed PubMed Central Google Scholar
Handforth C, Clegg A, Young C, Simpkins S, Seymour MT, Selby PJ, et al. The prevalence and outcomes of frailty in older cancer patients: a systematic review. Ann Oncol. 2015;26(6):1091–101. https://doi.org/10.1093/annonc/mdu540
Article CAS PubMed Google Scholar
Hernandez Torres C, Hsu T. Comprehensive Geriatric Assessment in the Older Adult with Cancer: A Review. Eur Urol Focus. 2017;3(4–5):330–9. https://doi.org/10.1016/j.euf.2017.10.010
Mohile SG, Dale W, Somerfield MR, Schonberg MA, Boyd CM, Burhenn PS, et al. Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology. Journal of Clinical Oncology. 2018;36(22):2326–47. https://doi.org/10.1200/jco.2018.78.8687
Article PubMed PubMed Central Google Scholar
Puts MT, Tapscott B, Fitch M, Howell D, Monette J, Wan-Chow-Wah D, et al. A systematic review of factors influencing older adults’ decision to accept or decline cancer treatment. Cancer Treat Rev. 2015;41(2):197–215. https://doi.org/10.1016/j.ctrv.2014.12.010
Mohile SG, Epstein RM, Hurria A, Heckler CE, Canin B, Culakova E, et al. Communication With Older Patients With Cancer Using Geriatric Assessment: A Cluster-Randomized Clinical Trial From the National Cancer Institute Community Oncology Research Program. JAMA Oncol. 2020;6(2):196–204. https://doi.org/10.1001/jamaoncol.2019.4728
Wildiers H, Heeren P, Puts M, Topinkova E, Janssen-Heijnen ML, Extermann M, et al. International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer. J Clin Oncol. 2014;32(24):2595–603. https://doi.org/10.1200/jco.2013.54.8347
Article PubMed PubMed Central Google Scholar
Dale W, Klepin HD, Williams GR, Alibhai SMH, Bergerot C, Brintzenhofeszoc K, et al. Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Systemic Cancer Therapy: ASCO Guideline Update. Journal of Clinical Oncology. 2023. https://doi.org/10.1200/jco.23.00933
Searle SD, Mitnitski A, Gahbauer EA, Gill TM, Rockwood K. A standard procedure for creating a frailty index. BMC Geriatr. 2008;8:24. https://doi.org/10.1186/1471-2318-8-24
Article PubMed PubMed Central Google Scholar
Rockwood K, Mitnitski A. Frailty in relation to the accumulation of deficits. J Gerontol A Biol Sci Med Sci. 2007;62(7):722–7. https://doi.org/10.1093/gerona/62.7.722
McCarthy AL, Peel NM, Gillespie KM, Berry R, Walpole E, Yates P, et al. Validation of a frailty index in older cancer patients with solid tumours. BMC Cancer. 2018;18(1):892. https://doi.org/10.1186/s12885-018-4807-6
Article CAS PubMed PubMed Central Google Scholar
Reiser E, Pötsch N, Seebacher V, Reinthaller A, Wimazal F, Fleischmann E, et al. Impact of frailty on the management of patients with gynecological cancer aged 80 years and older. Arch Gynecol Obstet. 2021;303(2):557–63. https://doi.org/10.1007/s00404-020-05807-9
Cohen HJ, Smith D, Sun CL, Tew W, Mohile SG, Owusu C, et al. Frailty as determined by a comprehensive geriatric assessment-derived deficit-accumulation index in older patients with cancer who receive chemotherapy. Cancer. 2016;122(24):3865–72. https://doi.org/10.1002/cncr.30269
Guerard EJ, Deal AM, Chang Y, Williams GR, Nyrop KA, Pergolotti M, et al. Frailty Index Developed From a Cancer-Specific Geriatric Assessment and the Association With Mortality Among Older Adults With Cancer. J Natl Compr Canc Netw. 2017;15(7):894–902. https://doi.org/10.6004/jnccn.2017.0122
Hembree T, Theou O, Thirlwell S, Reich RR, Cao B, Sehovic M, et al. A simple test-based frailty index to predict survival among cancer patients with an unplanned hospitalization: An observational cohort study. Cancer Medicine. 2021;10(17):5765–74. https://doi.org/10.1002/cam4.4107
Article PubMed PubMed Central Google Scholar
Jin X, Ren Y, Shao L, Guo Z, Wang C, He Y, et al. Prevalence of frailty and prediction of mortality in Chinese cancer patients using a frailty index-based clinical algorithm—A multicentre study. Cancer Medicine. 2021;10(18):6207–17. https://doi.org/10.1002/cam4.4155
Article CAS PubMed PubMed Central Google Scholar
Gomes F, Tay R, Chiramel J, Califano R. The Role of Targeted Agents and Immunotherapy in Older Patients with Non-small Cell Lung Cancer. Drugs & Aging. 2018;35(9):819–34. https://doi.org/10.1007/s40266-018-0573-z
Fletcher JA, Logan B, Reid N, Gordon EH, Ladwa R, Hubbard RE. How frail is frail in oncology studies? A scoping review. BMC Cancer. 2023;23(1). https://doi.org/10.1186/s12885-023-10933-z
Rockwood K, Andrew M, Mitnitski A. A Comparison of Two Appoaches to Measuring Frailty in Elderly People. Journal of Gerontology. 2007;62A:738–43. https://doi.org/10.1093/gerona/62.7.738
Rockwood K, Mitnitski A. Limits to deficit accumulation in elderly people. Mech Ageing Dev. 2006;127(5):494–6. https://doi.org/10.1016/j.mad.2006.01.002
Bruijnen CP, Van Harten-Krouwel DG, Koldenhof JJ, Emmelot-Vonk MH, Witteveen PO. Predictive value of each geriatric assessment domain for older patients with cancer: A systematic review. Journal of Geriatric Oncology. 2019;10(6):859–73. https://doi.org/10.1016/j.jgo.2019.02.010
Schulkes KJ, Souwer ET, Hamaker ME, Codrington H, van der Sar-van der Brugge S, Lammers JJ, et al. The Effect of A Geriatric Assessment on Treatment Decisions for Patients with Lung Cancer. Lung. 2017;195(2):225–31. https://doi.org/10.1007/s00408-017-9983-7
Article PubMed PubMed Central Google Scholar
Wang Y, Zhang R, Shen Y, Su L, Dong B, Hao Q. Prediction of chemotherapy adverse reactions and mortality in older patients with primary lung cancer through frailty index based on routine laboratory data. Clin Interv Aging. 2019;Volume 14:1187–97. https://doi.org/10.2147/cia.s201873
Article CAS PubMed PubMed Central Google Scholar
Narasimhulu DM, McGree ME, Weaver AL, Jatoi A, LeBrasseur NK, Glaser GE, et al. Frailty is a determinant of suboptimal chemotherapy in women with advanced ovarian cancer. Gynecologic Oncology. 2020;158(3):646–52. https://doi.org/10.1016/j.ygyno.2020.05.046
Article CAS PubMed Google Scholar
Ruiz J, Miller AA, Tooze JA, Crane S, Petty WJ, Gajra A, et al. Frailty assessment predicts toxicity during first cycle chemotherapy for advanced lung cancer regardless of chronologic age. J Geriatr Oncol. 2019;10(1):48–54. https://doi.org/10.1016/j.jgo.2018.06.007
van Walree IC, Scheepers E, van Huis-Tanja L, Emmelot-Vonk MH, Bellera C, Soubeyran P, et al. A systematic review on the association of the G8 with geriatric assessment, prognosis and course of treatment in older patients with cancer. J Geriatr Oncol. 2019;10(6):847–58. https://doi.org/10.1016/j.jgo.2019.04.016
Hamaker M, Lund C, Te Molder M, Soubeyran P, Wildiers H, Van Huis L, et al. Geriatric assessment in the management of older patients with cancer - A systematic review (update). Journal of Geriatric Oncology. 2022. https://doi.org/10.1016/j.jgo.2022.04.008
Kalsi T, Babic-Illman G, Fields P, Hughes S, Maisey N, Ross P, et al. The impact of low-grade toxicity in older people with cancer undergoing chemotherapy. British Journal of Cancer. 2014;111(12):2224–8. https://doi.org/10.1038/bjc.2014.496
Comments (0)